These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 38910000

  • 1. Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.
    Ono R, Sakamoto K, Kudo K, Sato A, Kudo K, Fujino H, Kawahara Y, Hashimoto H, Doi T, Yanagisawa R, Kawamata T, Miyazaki O, Nakazawa A, Ota Y, Kanegane H, Nakazawa Y, Horibe K, Saito AM, Manabe A, Usuki K, Kiyoi H, Morimoto A, Tojo A, Shioda Y.
    BMJ Open; 2024 Jun 23; 14(6):e084159. PubMed ID: 38910000
    [Abstract] [Full Text] [Related]

  • 2. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A, Shioda Y, Imamura T, Kudo K, Kitoh T, Kawaguchi H, Goto H, Kosaka Y, Tsunematsu Y, Imashuku S, Japan LCH Study Group.
    Int J Hematol; 2018 Aug 23; 108(2):192-198. PubMed ID: 29594922
    [Abstract] [Full Text] [Related]

  • 3. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
    Su M, Gao YJ, Pan C, Chen J, Tang JY.
    Pediatr Hematol Oncol; 2018 Aug 23; 35(7-8):385-392. PubMed ID: 30693828
    [Abstract] [Full Text] [Related]

  • 4. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H.
    Klin Padiatr; 2000 Aug 23; 212(4):139-44. PubMed ID: 10994540
    [Abstract] [Full Text] [Related]

  • 5. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
    Tang X, Gao J, Ma ZG, Guo X, Li Q, Wan Z, Sun JJ.
    Ann Med; 2021 Dec 23; 53(1):1537-1546. PubMed ID: 34459688
    [Abstract] [Full Text] [Related]

  • 6. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A, Ikushima S, Kinugawa N, Ishii E, Kohdera U, Sako M, Fujimoto J, Bessho F, Horibe K, Tsunematsu Y, Imashuku S, Japan Langerhans Cell Histiocytosis Study Group.
    Cancer; 2006 Aug 01; 107(3):613-9. PubMed ID: 16804933
    [Abstract] [Full Text] [Related]

  • 7. Additive Prognostic Impact of Gastrointestinal Involvement in Severe Multisystem Langerhans Cell Histiocytosis.
    Minkov M, Pötschger U, Thacker N, Astigarraga I, Braier J, Donadieu J, Henter JI, Lehrnbecher T, Rodriguez-Galindo C, Sieni E, Nanduri V, van den Bos C, Abla O, LCH Study Group of the Histiocyte Society.
    J Pediatr; 2021 Oct 01; 237():65-70.e3. PubMed ID: 34146548
    [Abstract] [Full Text] [Related]

  • 8. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
    Minkov M.
    Paediatr Drugs; 2011 Apr 01; 13(2):75-86. PubMed ID: 21351807
    [Abstract] [Full Text] [Related]

  • 9. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, Yasui M, Koga Y, Kobayashi R, Ishii E, Fujimoto J, Horibe K, Bessho F, Tsunematsu Y, Imashuku S.
    Int J Hematol; 2016 Jul 01; 104(1):99-109. PubMed ID: 27040279
    [Abstract] [Full Text] [Related]

  • 10. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Melon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S.
    Orphanet J Rare Dis; 2017 May 22; 12(1):95. PubMed ID: 28532436
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB, Xue HM, Chen YY, Huang K.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb 22; 21(1):146-9. PubMed ID: 23484709
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
    Adam Z, Pour L, Krejcí M, Neubauer J, Vanícek J, Vasků V, Hájek R.
    Vnitr Lek; 2008 Nov 22; 54(11):1063-80. PubMed ID: 19069680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW, Leung WK, Cheng FWT, Kumta SM, Chu WCW, Lee V, Shing MMK, Li CK.
    Arch Dis Child; 2017 Sep 22; 102(9):830-835. PubMed ID: 28442470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.